Solvothermal synthesis of rhombic shape GdF3:Tb3+ nanoparticles for biomedical applications
https://doi.org/10.37748/2686-9039-2023-4-2-4
EDN: DZTMNO
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Purpose of the study. In this work, we have investigated the mechanism of structure formation of GdF3:Tb3+(15 %) nanocrystals synthesized by solvothermal synthesis in the temperature range from RT to 200 °C with a step of 50 °C.
Materials and methods. Nanocrystals of GdF3:Tb3+(15 %) were synthesized by the solvothermal method using a high-pressure reactor (autoclave) designed for temperatures up to 250 °C. The structure, size and morphology were determined by transmission electron microscopy (TEM), the type of crystal lattice and the size of crystallites of nanoparticles were studied by X-ray diffraction (XRD), hydrodynamic size of nanoparticles, particle size distribution, ζ-potential, agglomeration of nanoparticles in colloidal solutions were determined by dynamic light scattering (DLS), the chemical composition of the nanocrystals surface was studied by Fourier-t ransform infra-red spectroscopy (FT-IR), the nanoparticles ability to absorb UV radiation was analyzed by UV-visible spectroscopy (UV-vis) and X-ray excited optical luminescence (XEOL).
Results. With an increase in the temperature of the synthesis reaction, a structural change in the crystallites phase occurs from hexagonal to orthorhombic. At low temperatures, agglomerated particles consisting of hexagonal nanocrystals are formed, while at a temperature higher than the boiling point of the solvent, monodisperse rhombic- shaped nanoparticles with orthorhombic phase are formed. At mild temperatures, agglomerated particles with different morphology and with mixed hexagonal and orthorhombic phases are formed. Based on the analysis of X-ray spectrum, it was found that the size of GdF3:Tb3+(15 %) nanocrystals varies from 10 to 50 nm for different synthesis temperature conditions (T = RT, 50 °C, 100 °C, 150 °C, 200 °C). The hydrodynamic size of nanoparticles decreases with increasing synthesis temperature. All GdF3:Tb3+(15 %) nanocrystals obtained at different temperatures are transparent to visible light and absorb UV radiation. Absorption in the UV region increases with an increase in the size of particle crystallites. Upon X-ray irradiation of the colloidal GdF3:Tb3+(15 %) solution, X-ray excited optical luminescence spectra showed emission peaks at 490 nm, 543 nm, 585 nm and 620 nm.
Conclusion. The mechanism of structure formation of rhombic‑ shaped GdF3:Tb3+(15 %) nanocrystals has been investigated. These monodisperse rhombic- shaped nanoparticles can be used for X-ray induced photodynamic therapy (X-PDT) of superficial, solid and deep-seated tumors.
Keywords
About the Authors
E. A. KuchmaRussian Federation
Elena A. Kuchma – engineer, The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0002-9440-4860, ResearcherID: U-5776-2019, Scopus Author ID: 5719554859
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
O. E. Polozhentsev
Russian Federation
Oleg E. Polozhentsev – Cand. Sci. (Geol.-Min.), senior researcher, The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0002-2077-9512, SPIN: 1959-4459, AuthorID: 788015, ResearcherID: N-9555-2015,Scopus Author ID: 3527339900
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
I. A. Pankin
Russian Federation
Ilia A. Pankin – Cand. Sci. (Geol.-Min.), senior researcher, The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0003-2784-4839, SPIN: 3152-7393, AuthorID: 793405, ResearcherID: P-3517-2015, Scopus Author ID: 5650064290
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
A. N. Bulgakov
Russian Federation
Aleksei N. Bulgakov – laboratory assistant,The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
P. A. Rud
Russian Federation
Polina A. Rud – laboratory assistant, The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
A. V. Soldatov
Russian Federation
Alexander V. Soldatov – scientific director, professor, doctor of physical sciences, The Smart Materials Research Institute at the Southern Federal University, Rostov-on-Don, Russian Federation.
ORCID: https://orcid.org/0000-0001-8411-0546, SPIN: 2132-5994, AuthorID: 1685, ResearcherID: E-9323-2012, Scopus Author ID: 7102129914
Competing Interests:
the authors state that there are no conflicts of interest to disclose.
References
1. Suleimanov EA, Khomyakov VM, Serova LG, Moskvicheva LI, Filonenko EV, Kaprin AD. Intraoperative photodynamic therapy for metastatic peritoneal tumors. Research and Practical Medicine Journal. 2016;3(3):59-67. (In Russ.). https://doi.org/10.17709/2409-2231-2016-3-3-6, EDN: WKUVGF
2. Allison RR, Moghissi K. Photodynamic Therapy (PDT): PDT Mechanisms. Clin Endosc. 2013 Jan;46(1):24-29. https://doi.org/10.5946/ce.2013.46.1.24
3. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018 Oct;106:1098-1107. https://doi.org/10.1016/j.biopha.2018.07.049
4. Kamkaew A, Chen F, Zhan Y, Majewski RL, Cai W. Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. ACS Nano. 2016 Apr 26;10(4):3918-3935. https://doi.org/10.1021/acsnano.6b01401
5. Ren XD, Hao XY, Li HC, Ke MR, Zheng BY, Huang JD. Progress in the development of nanosensitizers for X-ray-induced photodynamic therapy. Drug Discov Today. 2018 Oct;23(10):1791-1800. https://doi.org/10.1016/j.drudis.2018.05.029
6. Polozhentsev OE, Pankin IA, Khodakova DV, Medvedev PV, Goncharova AS, Maksimov AY, et al. Synthesis, Characterization and Biodistribution of GdF3:Tb3+@RB Nanocomposites. Materials (Basel). 2022 Jan 13;15(2):569. https://doi.org/10.3390/ma15020569
7. Zhang X, Hayakawa T, Nogami M, Ishikawa Y. Selective Synthesis and Luminescence Properties of Nanocrystalline GdF3:Eu3+ with Hexagonal and Orthorhombic Structures. Journal of Nanomaterials. 2010 Dec 27;2010:e651326. https://doi.org/10.1155/2010/651326
8. Samanta T, Hazra C, Praveen AE, Ganguli S, Mahalingam V. Synthesis of Hexagonal-Phase Eu3+-Doped GdF3 Nanocrystals above Room Temperature by Controlling the Viscosity of the Solvents. European Journal of Inorganic Chemistry. 2016;2016(6):802-807. https://doi.org/10.1002/ejic.201501146
9. Sui Z, Wang J, Huang D, Wang X, Dai R, Wang Z, et al. Orthorhombic-to-Hexagonal Phase Transition of REF3 (RE = Sm to Lu and Y) under High Pressure. Inorg Chem. 2022 Oct 3;61(39):15408-15415. https://doi.org/10.1021/acs.inorgchem.2c01891
Supplementary files
Review
For citations:
Kuchma E.A., Polozhentsev O.E., Pankin I.A., Bulgakov A.N., Rud P.A., Soldatov A.V. Solvothermal synthesis of rhombic shape GdF3:Tb3+ nanoparticles for biomedical applications. South Russian Journal of Cancer. 2023;4(2):39-46. https://doi.org/10.37748/2686-9039-2023-4-2-4. EDN: DZTMNO